Table 1.
Data among HCV-positive patients who underwent hepatectomy for HCC carrying GG, GA, and AA allele at rs2596542 (MICA).
| rs2596542 | GG (n = 30) | GA (n = 22) | AA (n = 12) | P value |
|---|---|---|---|---|
| Age (y), mean ± SD | 68 ± 1 | 69 ± 1 | 72 ± 2 | n.s |
| Sex (male/female), n | 21/9 | 18/4 | 11/1 | n.s |
| Platelet count (×104/μL), mean ± SD | 13.1 ± 1.0 | 14.8 ± 1.2 | 13.8 ± 1.6 | n.s |
| Total bilirubin level (mg/dL), mean ± SD | 0.9 ± 0.07 | 0.9 ± 0.08 | 0.9 ± 0.1 | n.s |
| Prothrombin time (%), mean ± SD | 0/11/10 | 1/8/13 | 0/1/7 | n.s |
| ICGR15 (%), mean ± SD | 15.9 ± 1.4 | 16.5 ± 1.7 | 14.7 ± 2.3 | n.s |
| Operative time (min), mean ± SD | 369 ± 19 | 342 ± 23 | 322 ± 31 | n.s |
| Intraoperative bleeding (mL), mean ± SD | 779 ± 100 | 586 ± 118 | 617 ± 160 | n.s |
| Maximum tumor size (cm), mean ± SD | 3.7 ± 0.4 | 3.3 ± 0.5 | 3.3 ± 0.8 | n.s |
| AFP level (ng/mL), mean (minimum–maximum) | 797 (2.3–17156) | 284 (2–4746) | 907 (2.2–10368) | n.s |
| DCP level (mAU/mL), mean (minimum–maximum) | 2484 (9–46561) | 2710 (10–31134) | 538 (9–3817) | n.s |
| Stage (I/II/III/IV), n | 7/13/9/1 | 3/11/8/0 | 1/11/0/0 | n.s |
| Tumor differentiation (well/moderate/poorly), n | 5/22/3 | 7/13/2 | 3/7/2 | n.s |
| Fibrosis stage (F0-2/F3-4), n | 13/17 | 11/11 | 4/8 | n.s |
AFP: alpha-fetoprotein, DCP: des-gamma-carboxy prothrombin, HCC: hepatocellular carcinoma, ICGR15: indocyanine green retention at 15 minutes, and n.s: not significant.